Elicio Therapeutics, Inc. (ELTX)

NASDAQ: ELTX · Real-Time Price · USD

12.53

+1.04 (9.05%)

At close: Jun 3, 2026, 4:00 PM EDT

12.56

+0.03 (0.24%)

After-hours: Jun 3, 2026, 4:31 PM EDT

Elicio Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	231	142	56	80	-	-
Market Cap Growth	146.96%	151.89%	-29.77%	-	-	-
Enterprise Value	229.89	136.63	63.77	73.21	0	0
Last Close Price	12.53	7.96	5.10	8.34	-	-
PB Ratio	-	86.61	-4.97	7.04	-	-
P/TBV Ratio	-144.90	74.51	-5.50	3.71	-	-
Debt / Equity Ratio	-9.25	8.25	-2.22	0.53	0.76	0.04
Net Debt / Equity Ratio	0.42	-2.48	-0.74	-0.53	-0.01	-1.03
Net Debt / EBITDA Ratio	0.02	0.11	-0.19	0.17	-0.06	2.19
Net Debt / FCF Ratio	0.02	0.11	-0.23	0.18	-0.06	1.59
Asset Turnover	-	0	0	0	0	0.39
Quick Ratio	2.07	2.29	1.53	1.32	0.90	7.93
Current Ratio	2.24	2.38	1.80	1.68	1.56	8.08
Return on Equity (ROE)	-40386.90%	817.92%	-170157.00%	-346.95%	-62.39%	1220.60%
Return on Assets (ROA)	-154.81%	-139.58%	-162.63%	-143.52%	-39.83%	-54.65%
Return on Invested Capital (ROIC)	-497.98%	-440.66%	-409.30%	-269.75%	-209.03%	-72.20%
Return on Capital Employed (ROCE)	-226.30%	-219.22%	-264.27%	-215.42%	-46.99%	-313.02%
Buyback Yield / Dilution	-29.18%	-25.48%	-141.35%	-242.51%	0.00%	0.00%
Total Shareholder Return	-29.18%	-25.48%	-141.35%	-242.51%	0.00%	0.00%

SEC Filings: 10-K · 10-Q